Viewing StudyNCT00135330



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00135330
Status: COMPLETED
Last Update Posted: 2015-04-07
First Post: 2005-08-24

Brief Title: An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
Lilly View
diabetes View
exenatide View
rosiglitazone View
Amylin View